-
31دورية أكاديمية
المؤلفون: Holman, Rury R.1 rury.holman@dtu.ox.ac.uk, Peterson, Eric D.2, Rutter, Martin K (AUTHOR), Wright, Alison K (AUTHOR), Ashcroft, Darren M (AUTHOR)
المصدر: New England Journal of Medicine. 12/17/2015, Vol. 373 Issue 25, p2479-2479. 1p.
مصطلحات موضوعية: *CARDIOVASCULAR diseases, *HETEROCYCLIC compounds, *HYPOGLYCEMIC agents, *TYPE 2 diabetes, *DISEASE complications
-
32دورية أكاديمية
المؤلفون: Turner, Robert C.1, Holman, Rury R.1
المصدر: Cardiology. 1999, Vol. 91 Issue 3, p203-204. 2p.
مصطلحات موضوعية: *CARDIOVASCULAR disease treatment, *TYPE 2 diabetes, *ORAL therapy for diabetes, *HYPOGLYCEMIC agents, *HYPOGLYCEMIC sulfonylureas, *PHENFORMIN
-
33دورية أكاديمية
المؤلفون: Holman, Rury R., Kahn, Steven E., Haffner, Steven M., Zinman, Bernard, Viberti, Giancarlo F., Herman, William H., Lachin, John M., Kravitz, Barbara G., Heise, Mark A.
المصدر: Diabetes. Jun2007 Supplement 1, Vol. 56, pA66-A66. 1/3p. 1 Chart.
مصطلحات موضوعية: *THERAPEUTICS, *HYPOGLYCEMIC agents, *GLIBENCLAMIDE, *AGE, *GLYCOSYLATED hemoglobin
-
34دورية أكاديمية
المؤلفون: Haffner, Steven M., Kahn, Steven E., Zinman, Bernard, Holman, Rury R., Viberti, Giancarlo F., Herman, William H., Lachin, John M., Kravitz, Barbara G., Heise, Mark A.
المصدر: Diabetes; Jun2007 Supplement 1, Vol. 56, pA176-A176, 1/4p, 1 Graph
مصطلحات موضوعية: DRUG efficacy, HYPOGLYCEMIC agents, C-reactive protein, WEIGHT gain, PEOPLE with diabetes, TYPE 2 diabetes
-
35دورية أكاديمية
المؤلفون: Herman, William H., Haffner, Steven M., Kahn, Steven E., Zinman, Bernard, Holman, Rury R., Viberti, Giancarlo F., Lachin, John M., Kravitz, Barbara G., Heise, Mark A.
المصدر: Diabetes; Jun2007 Supplement 1, Vol. 56, pA146-A146, 1/4p
مصطلحات موضوعية: HYPOGLYCEMIC agents, TYPE 2 diabetes treatment, PEOPLE with diabetes, HYPOGLYCEMIC sulfonylureas, HYPOGLYCEMIA, WEIGHT gain, RANDOMIZED controlled trials
مصطلحات جغرافية: UNITED Kingdom
-
36دورية أكاديمية
المؤلفون: Bethel, M. Angelyn1 (AUTHOR), Stevens, Susanna R.2 (AUTHOR), Buse, John B.3 (AUTHOR), Choi, Jasmine4 (AUTHOR), Gustavson, Stephanie M.4 (AUTHOR), Iqbal, Nayyar4 (AUTHOR), Lokhnygina, Yuliya2 (AUTHOR), Mentz, Robert J.2 (AUTHOR), Patel, Rishi A.1 (AUTHOR), Öhman, Peter4 (AUTHOR), Schernthaner, Guntram5 (AUTHOR), Lecube, Albert6 (AUTHOR), Hernandez, Adrian F.2 (AUTHOR), Holman, Rury R.1 (AUTHOR)
المصدر: Circulation. 4/28/2020, Vol. 141 Issue 17, p1360-1370. 11p.
مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *TYPE 2 diabetes, *DRUGS, *PLACEBOS, *DIABETES complications, *STROKE prevention, *STROKE-related mortality, *STROKE, *MYOCARDIAL infarction, *BLOOD sugar, *HYPOGLYCEMIC agents, *RISK assessment, *LONGITUDINAL method, MYOCARDIAL infarction-related mortality
-
37دورية أكاديمية
المؤلفون: Sharma, Abhinav1,2 (AUTHOR), Pagidipati, Neha J.3 (AUTHOR), Califf, Robert M.4 (AUTHOR), McGuire, Darren K.5 (AUTHOR), Green, Jennifer B.3 (AUTHOR), Demets, Dave6 (AUTHOR), George, Jyothis Thomas7 (AUTHOR), Gerstein, Hertzel C.8 (AUTHOR), Hobbs, Todd9 (AUTHOR), Holman, Rury R.10 (AUTHOR), Lawson, Francesca C.11 (AUTHOR), Leiter, Lawrence A.12 (AUTHOR), Pfeffer, Marc A.13 (AUTHOR), Reusch, Jane14 (AUTHOR), Riesmeyer, Jeffrey S.15 (AUTHOR), Roe, Matthew T.3 (AUTHOR), Rosenberg, Yves16 (AUTHOR), Temple, Robert17 (AUTHOR), Wiviott, Stephen18 (AUTHOR), McMurray, John19 (AUTHOR)
المصدر: Circulation. 3/10/2020, Vol. 141 Issue 10, p843-862. 20p.
مصطلحات موضوعية: *TYPE 2 diabetes, *GLYCOSYLATED hemoglobin, *GLUCOSE metabolism, *CARDIOVASCULAR disease prevention, *PREVENTION of drug side effects, *RELATIVE medical risk, *RESEARCH, *GLYCINE, *GOVERNMENT regulation, *PHENYLBUTAZONE, *HETEROCYCLIC compounds, *RESEARCH methodology, *HYPOGLYCEMIC agents, *CARDIOVASCULAR diseases, *EVALUATION research, *MEDICAL cooperation, *MEDICAL protocols, *COMPARATIVE studies, *RESEARCH funding, *TOLBUTAMIDE
مصطلحات جغرافية: UNITED States
الشركة/الكيان: EUROPEAN Medicines Agency , UNITED States. Food & Drug Administration
-
38دورية أكاديمية
المؤلفون: Pagidipati, Neha J.1 neha.pagidipati@dm.duke.edu, Navar, Ann Marie1, Pieper, Karen S.1, Green, Jennifer B.1, Bethel, M. Angelyn2, Armstrong, Paul W.3, Josse, Robert G.4, McGuire, Darren K.5, Lokhnygina, Yuliya1, Cornel, Jan H.6, Halvorsen, Sigrun7, Strandberg, Timo E.8,9, Delibasi, Tuncay10, Holman, Rury R.2, Peterson, Eric D.1, TECOS Study Group (CORPORATE AUTHOR)
المصدر: Circulation. 9/26/2017, Vol. 136 Issue 13, p1193-1203. 11p.
مصطلحات موضوعية: *CARDIOVASCULAR disease prevention, *PEOPLE with diabetes, *DIABETES, *ASPIRIN, *ACE inhibitors, *HYPOGLYCEMIC agents, *TYPE 2 diabetes complications, *ANGIOTENSIN receptors, *BLOOD pressure, *CARDIOVASCULAR diseases, *COMPARATIVE studies, *LONGITUDINAL method, *LOW density lipoproteins, *RESEARCH methodology, *MEDICAL cooperation, *TYPE 2 diabetes, *RESEARCH, *RESEARCH funding, *SMOKING, *LOGISTIC regression analysis, *EVALUATION research, *TREATMENT effectiveness, *PROPORTIONAL hazards models, *BLIND experiment, *DISEASE complications, *THERAPEUTICS, CARDIOVASCULAR disease related mortality, DISEASE relapse prevention
-
39دورية أكاديمية
المؤلفون: Becker, Frauke1 (AUTHOR), Dakin, Helen A.1 (AUTHOR) helen.dakin@ndph.ox.ac.uk, Reed, Shelby D.2 (AUTHOR), Li, Yanhong2 (AUTHOR), Leal, José1 (AUTHOR), Gustavson, Stephanie M.3 (AUTHOR), Wittbrodt, Eric3 (AUTHOR), Hernandez, Adrian F.2 (AUTHOR), Gray, Alastair M.1 (AUTHOR), Holman, Rury R.1,4 (AUTHOR)
المصدر: Diabetes Research & Clinical Practice. Jan2022, Vol. 183, pN.PAG-N.PAG. 1p.
مصطلحات موضوعية: *COST effectiveness, *TYPE 2 diabetes, *EXENATIDE, *GLUCAGON-like peptide-1 receptor, *HYPOGLYCEMIC agents, *COST benefit analysis, *QUALITY-adjusted life years, *LONGITUDINAL method
مصطلحات جغرافية: UNITED Kingdom
-
40دورية أكاديمية
المؤلفون: Wright, Alex D.1, Cull, Carole A.2 carole.cull@dtu.ox.ac.uk, Macleod, Kenneth M.3, Holman, Rury R.2, UKPDS Group (CORPORATE AUTHOR)
المصدر: Journal of Diabetes & its Complications. Nov2006, Vol. 20 Issue 6, p395-401. 7p.
مصطلحات موضوعية: *HYPOGLYCEMIC agents, *DIABETES complications, *CLINICAL medicine research, *GLUCOSE synthesis